Quotable: Top Experts On Policy Hot Topics

 
• By Neena Brizmohun
  
Generate a summary of this article
Listen to this article
Beta

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

• Source: Shutterstock

“Creating an accessible repository of these AI-generated antigen designs is a critical first step in creating such a vaccine library, the benefits of which would be game-changing.” – The Coalition for Epidemic Preparedness Innovations’ Melanie Saville on using artificial intelligence to expedite the vaccine development process. Find out more: How AI Can Help Reduce Vaccine R&D From A Year To A Matter Of Weeks

“When you have Republicans complaining about excessive profits, that is pretty bad." – US House Committee on Oversight and Accountability...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from International

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

WHO To Finalize Preferred & Critical Characteristics Of New Mpox Human Vaccines

 
• By Vibha Sharma

To help sponsors developing candidate mpox vaccines, the World Health Organization will soon be finalizing guidance on the preferred and minimum characteristics these products must satisfy regarding efficacy, dose regimen and other aspects to secure regulatory approval.

WHO Urges Countries To Curb Spread Of Mpox With Vaccines, Therapeutics & Other Actions

 
• By Ian Schofield

The WHO’s emergency committee has warned of a lack of understanding of the epidemiology of mpox, the limited availability of vaccines, and the complexities of donations and procurement.

ICH Explores New Platform To Facilitate Global Evaluation Of CMC Changes

 
• By Vibha Sharma

An ongoing collaborative initiative involving global regulators assessing post-approval manufacturing changes has highlighted the need to establish a standardized platform that can facilitate the submission and regulatory evaluation of such changes.

More from Geography

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description

Diversity Action Plans: What To Submit And When

 
• By Nielsen Hobbs

With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.